Corvia Medical

World’s First InterAtrial Shunt Proven to Reduce Heart Failure Symptoms.

Corvia Medical, Inc., is dedicated to revolutionizing the treatment of heart failure with first-in-class structural heart devices. The company has developed the world’s first transcatheter device designed to treat heart failure with preserved (HFpEF) or mid-range (HFmrEF) ejection fraction, previously known as diastolic heart failure (DHF). The innovative InterAtrial Shunt Device (IASD^®) is clinically proven to reduce elevated left atrial pressure (LAp), which is the main cause of heart failure symptoms.

Clinical Study Information

Corvia Medical is enrolling patients in the REDUCE LAP HF II Study. To learn more, visit treatmyheartfailure.com.

Hear From Our Patients

Hear About REDUCE LAP-HF I

Hear From Our Sites

Patients Eager to Test Device That Could Ease Heart Failure Symptoms

Ohio State Evaluates First Transcatheter Implant for Diastolic Heart Failure

World’s First InterAtrial Shunt Proven to Reduce Heart Failure Symptoms.

Press Releases

Clinical Study Information

Hear From Our Patients

Hear About REDUCE LAP-HF I

Hear From Our Sites